Sanofi (ENXTPA:SAN) experienced a 4% decline over the past week despite a largely unchanged market. The recent events, including the FDA approval of Dupixent for a rare skin condition and the ...

MONROE COUNTY, Pa. - Sanofi, maker of anti-inflammation drug Dupixent, will report third-quarter earnings Friday before the opening of U.S. markets. Paris-based Sanofi is the parent company of ...

The two organisations signed a memorandum of understanding to this effect at the BIO International Convention 2025, in Boston, USA, recently. Dr Noura Khamis Al Ghaithi, Under-Secretary of the ...

Sanofi successfully prices €1.5 billion bond issue Paris, June 17, 2025 - Sanofi announces that it has successfully priced its offering of €1.5 billion of notes across 2 tranches: €750 million ...

Sanofi successfully prices €1.5 billion bond issue. Paris, June 17, 2025- Sanofi announces that it has successfully priced its offering of €1.5 billion of notes across 2 tranches:. About ...

BofA Securities lowered its price target on Sanofi (SAN:FP) (NASDAQ: SNY) to EUR8.40 from EUR8.48 on Tuesday, while maintaining a Buy rating on the French pharmaceutical company’s stock. With a ...

Paris, June 17, 2025 - Sanofi announces that it has successfully priced its offering of €1.5 billion of notes across 2 tranches: €750 million fixed-rate notes, due June 2029, bearing interest at an ...

Sanofi successfully prices €1.5 billion bond issue Paris, June 17, 2025 - Sanofi announces that it has successfully priced its offering of €1.5 billion of notes across 2 tranches: €750 million ...

POCONO TWP., Pa. - Sanofi Pasteur has gotten FDA approval for its new manufacturing facility in Monroe County. The move will allow the global pharmaceutical company to expand the production and ...

Didier Martin, Head of Pharma at Sanofi-Aventis Vietnam, highlighted the value of strategic alliances in healthcare innovation. "At Sanofi, we believe collaboration is crucial for driving innovation ...

Sanofi and Regeneron Pharmaceuticals said they got Food and Drug Administration approval for anti-inflammatory drug Dupixent as a treatment for a rare skin disease, adding an eighth indication in ...